This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global oral proteins and peptides market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the oral proteins and peptides market. The secondary sources used for this study include the World Health Organization (WHO), National Institutes of Health (NIH), United States Food and Drug Administration (US FDA), European Medicines Agency (EMA), National Center for Biotechnology Information (NCBI), BioPharm International, International Diabetes Federation, ScienceDirect, ClinicalTrials.gov, PubMed, European Federation of Pharmaceutical Industries and Associations (EFPIA), European Lead Factory (ELF), India Brand Equity Foundation (IBEF), UK Research Partnership Investment Fund (UKRPIF), Pharmaceutical Research and Manufacturers of America (PhRMA), Eurostat, and Factiva, research journals; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global oral proteins and peptides market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as pharmaceutical and biotechnology companies, CROs, CMOs, and academic & research institutes, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across six major regions, including the Asia Pacific, North America, Europe, Latin America, Middle East and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Bottom-up approach were used to estimate and validate the total size of the oral proteins and peptides market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
-
The list of approved oral proteins and peptides was identified through extensive secondary and primary research.
-
The oral proteins and peptides products in pipeline were identified from clinical trial registries, secondary and primary research for drug classes of peptide and protein therapeutics.
-
The revenues generated from these oral proteins and peptides have been determined through annual reports, and secondary sources (including paid database)
-
The products were mapped as per the segments of the market. Percentage shares, splits were determined based on the revenue contributed to each of the segments. This was verified using secondary sources and by industry experts
-
All assumptions, approaches and individual shares/revenue estimates were validated through expert interviews.
Global Oral Proteins and Peptides Market Size: Bottom-up Approach
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Oral Proteins and Peptides refer to therapeutic drugs composed of proteins or peptides (short chains of amino acids) that are intended to be administered orally. These biologically active molecules are designed to treat various medical conditions, including chronic diseases such as diabetes, hormonal disorders, and autoimmune disorders.
Stakeholders
-
Pharmaceutical & biotechnology companies
-
Hospitals
-
Specialty clinics
-
Long term care facilities
-
Patient advocacy organizations
-
Academic researchers and government research organizations
-
Private research institutes
-
Contract manufacturing organizations (CMOs)
-
Contract research organizations (CROs)
-
Venture capitalists
Report Objectives
-
To define, describe, and forecast the oral proteins and peptides market based on molecule, drug class, therapeutic area, formulation, end user, and region
-
To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
-
To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall oral proteins and peptides market
-
To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
-
To forecast the size of the market segments with respect to six main regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
-
To profile the key players in the oral proteins and peptides market and comprehensively analyze their product portfolios, market positions, and core competencies
-
To track and analyze competitive developments in the oral proteins and peptides market, such as acquisitions, product launches/approvals, expansions, agreements, partnerships, and collaborations
-
To benchmark players within the oral proteins and peptides market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business strategy and product strategy
HIGHEST CAGR MARKET IN 2024
NORTH AMERICA FASTEST GROWING MARKET IN THE REGION
Growth opportunities and latent adjacency in Oral Proteins & Peptides Market